This meeting took place in 2012



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Cancer and Metabolism (Q3)


Organizer(s) Reuben J. Shaw and David M. Sabatini
February 12—17, 2012
Fairmont Banff Springs • Banff, Alberta Canada
Abstract Deadline: Oct 13, 2011
Late Abstract Deadline: Nov 14, 2011
Scholarship Deadline: Oct 13, 2011
Early Registration Deadline: Dec 12, 2011

Sponsored by Astellas Pharma Inc., Celgene Corporation, Pfizer Inc. and Takeda Pharmaceutical Company Limited


Summary of Meeting:
Although altered glucose metabolism was first noted as a characteristic of tumor cells by Otto Warburg in the 1920s, the molecular underpinning for this observation did not begin to be appreciated fully until the past decade. This area has exploded over the last five years with the identification of extensive interactions of genuine tumor suppressor genes and oncogenes with metabolic control. The increased biosynthetic needs of tumor cells demand a reprogramming of cellular metabolism, which also creates increased energy demands and makes tumor cells more vulnerable to interventions targeting their metabolism. The goal of the Keystone Symposia meeting on Cancer and Metabolism is to bring together leaders in the fields of cancer and metabolic control with those studying the signaling pathways linking and governing each. The latest discoveries will be discussed as well as how this knowledge can be exploited to design future cancer therapeutics. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Advances in Hypoxic Signaling: From Bench to Bedside, which will share a keynote address and a plenary session with this meeting.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Mariam Aghajan
Ionis Pharmaceuticals, USA

Kivanc Birsoy
Rockefeller University, USA

Gwen Buel
Harvard University, USA

Jonathan L. Coloff
Harvard Medical School, USA

Jessica J. Howell
Harvard School of Public Health, USA

Thomas P. Lynch
University of Medicine and Dentistry of New Jersey, USA

Marie Morfouace
St Jude Children's Research Hospital, USA

Camilla Norrmén
ETH Zurich, Switzerland

John K. Simmons
NCI, National Institutes of Health, USA

Kevin J. Williams
University of California, Los Angeles, USA

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Francesca Alvarez-Calderon
University of Colorado - Anschutz Medical Campus, USA

Jihan Osborne
University of Texas Southwestern Medical Center, USA

National Cancer Institute (NCI) Scholarship Recipients

Katharine V. Brown
University of California, Berkeley, USA

Andrew Mullen
University of Texas Southwestern Medical Center, USA